HOME ZACKS RESEARCH FUNDS PORTFOLIO BROKER RESEARCH MARKETS SCREENING EDUCATION SERVICES
Earnings    EPS Surprises    Mutual Funds    Options    My Account    Help    

PeopleandPicks.com is Zacks' Community Website
Find great stocks and great stock pickers in our online community. It's social, it's profitable and it's Free! Join the fun at PeopleandPicks.com
Quote:
Login Free Membership
Search:

Top Zacks Features
Free Membership
Premium Home
Zacks Rank
Equity Research
My Portfolio
Stock Screener
Profit Tracks
Mutual Funds
Options
Zacks Video
RSS Feed
Profit from the Pros

Subscription Services
Product Guide
Zacks Premium
Zacks Elite
Method for Trading
Chart Patterns Trader
Double Your Money
ETF Trader
Growth Trader
Options Trader
Small Cap Trader
Strategic Investor
Surprise Trader
Top 10 Stocks
Value Trader
Special Reports
Research Wizard

Zacks Premium
Get profitable stock
picks and timely
market advice in
Zacks.com`s Free
Daily Newsletter!

Free Registration

View the Archive


GENZ: Genzyme Cp - Stock News Enter Ticker:
 

QuoteEstimatesCharts Company ReportsNewsFinancials
  Company News |  Zacks Commentary
GENZYME CP (NASD)
GENZ 50.05 0.42 (0.85%) Vol.  2,974,330 16.00 CST

Nov 20, 2009 SmarTrend's Candlestick Scanner Detects Possible Bullish Engulfing Pattern for Genzyme (GENZ)
Nov 19, 2009 Global Market Perspective Review on JRCC, HLCS, ISPH, CHIP, GENZ andDSCO From TheFortuneFinancial.com
Nov 18, 2009 Genzyme Gets FDA Complete Response Letter on Lumizyme Application
Nov 18, 2009 GENZ's Lumizyme Approval Delayed
Nov 18, 2009 Genzyme Announces Results of Phase 2/3 Trial of Advanced Phosphate Binder
Nov 17, 2009 Zacks Bull and Bear of the Day Highlights: Sealed Air Corporation, Hologic, Inc., Genzyme Corp., Shire plc and Protalix BioTherapeutics Inc.
Nov 17, 2009 Data from Mipomersen Phase 3 Trial in hoFH Patients Presented at AHA
Nov 16, 2009 Targeted Genetics Corporation Reports Third Quarter 2009 Financial Results
Nov 16, 2009 Genzyme Receives Complete Response Letter on Lumizyme Application
Nov 16, 2009 BiomedReports: News and FDA Updates for Celgene (NASDAQ:CELG), Genzyme (Nasdaq:GENZ)
Nov 16, 2009 BUYINS.NET: Genzyme (GENZ) Daily Short Sale Trading Volume Through 11-13-09. Over 72 Million Shares Shorted in Past 3 Months.
Nov 15, 2009 Genzyme Down 6.5% Since SmarTrend's Sell Recommendation
Nov 13, 2009 Drug company warns of contamination
Nov 13, 2009 Genzyme Issues Letters to U.S. Healthcare Providers
Nov 13, 2009 FDA Said Pieces Of Steel, Rubber, Fiber Found In Drugs Made By Genzyme (GENZ)
 
ZACKS COMMENTARY FOR GENZ
Nov 19, 2009 Zacks Blog: Genzyme’s Problems Continue
Nov 19, 2009 Zacks Blog: Zacks #5 Rank Additions for Thursday
Nov 17, 2009 Zacks Blog: GENZ’s Lumizyme Approval Delayed
Nov 17, 2009 Zacks Blog: Zacks Bull and Bear of the Day Highlights: Sealed Air Corporation, Hologic, Inc., Genzyme Corp., Shire plc and Protalix BioTherapeutics Inc.
Nov 16, 2009 Zacks Blog: Contamination Issues Haunt GENZ
Nov 12, 2009 Zacks Blog: Osiris Posts Loss
Nov 11, 2009 Zacks Blog: Isis Loss Widens
Nov 04, 2009 Zacks Blog: Zacks Bull and Bear of the Day Highlights: McDonald's, Genzyme, Berkshire Hathaway, Burlington Northern Santa Fe Corp and Berkshire Hathaway
Nov 04, 2009 Bear of the Day: Genzyme Corp. (GENZ)
Nov 03, 2009 Zacks Equity Research: Report for GENZ
Oct 26, 2009 Zacks Blog: Zacks #5 Rank Additions for Monday
Oct 23, 2009 Zacks Blog: Isis Diabetes Drug Shows Promise

 
About Zacks | Advertise | Media | Careers | Contact Us | Help
Disclaimer | Privacy Policy | Sitemap
NYSE and AMEX data is at least 20 minutes delayed.  NASDAQ data is at least 15 minutes delayed.
Copyright 2009 Zacks Investment Research